RELAXO — Relaxo Footwears Balance Sheet
0.000.00%
- IN₹82.16bn
- IN₹82.20bn
- IN₹27.02bn
Annual balance sheet for Relaxo Footwears, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,818 | 2,659 | 1,692 | 2,915 | 2,284 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,132 | 3,346 | 4,339 | 3,433 | 2,992 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,870 | 11,936 | 12,464 | 12,346 | 11,935 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11,038 | 12,072 | 13,817 | 13,844 | 14,531 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 23,826 | 24,948 | 27,139 | 27,625 | 29,489 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,610 | 4,707 | 5,195 | 4,508 | 5,126 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,225 | 6,397 | 7,128 | 6,644 | 7,426 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 17,601 | 18,551 | 20,011 | 20,981 | 22,064 |
| Total Liabilities & Shareholders' Equity | 23,826 | 24,948 | 27,139 | 27,625 | 29,489 |
| Total Common Shares Outstanding |